Drawing for F900

USPTO serial 88103599

F900

Reviewed by CopyMark Law Group

Reg. 5721914Status 702Registered
Filing date
Status date
Registration date
Apr 9, 2019
Examiner
MAHONEY, PAULA M
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with F900?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Peter J. Ims

Peter J. Ims Westman, Champlin & Koehler P.A.121 South Eighth Street, Suite 1100Minneapolis, MN 55402United States

Goods and services

ClassDescriptionStatusFirst use
0073D printersACTIVEAug 1, 2018

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 20, 2026EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Aug 20, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 20, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 20, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 21, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 21, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 21, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 21, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 21, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Feb 27, 2025NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Feb 27, 2025C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Feb 27, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Oct 24, 2024E815TEAS SECTION 8 & 15 RECEIVED—
Apr 9, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Nov 21, 2019TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 9, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 22, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 22, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 2, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 15, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 14, 2018DOCKASSIGNED TO EXAMINER—
Sep 11, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 7, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance